Literature DB >> 9509542

Diagnostic embryoscopy and fetoscopy in the first trimester of pregnancy.

Y Ville1, A Khalil, T Homphray, G Moscoso.   

Abstract

Embryoscopy is the examination of the embryo at 9-10 weeks' gestation through the intact membranes by introducing an endoscope into the exocoelomic space transcervically or transabdominally. This is likely to remain confined to the management of early pregnancy in selected families affected by recurrent genetic syndromes with recognizable external fetal abnormalities. The procedure-related risk of fetal loss is around 12 per cent. Fetoscopy is the examination of the fetus after 11 weeks' gestation. This is performed transabdominally in the amniotic fluid. The technique has evolved with the miniaturization of the optical device by using fibre-optics technology. This procedure is likely to find new applications with the development of ultrasound examination at 10-14 weeks' gestation in order to, either confirm, or rule out suspected external fetal abnormalities. Amniocentesis can be performed at the same time. The procedure-related risk is likely to remain below 10 per cent but no accurate figures can be drawn from the literature.

Entities:  

Mesh:

Year:  1997        PMID: 9509542

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  3 in total

1.  Fetoscopic imaging of isolated cleft lip.

Authors:  Léonardo Gucciardo; Tim Van Mieghem; Pierre Bernard; Jan Deprest
Journal:  BMJ Case Rep       Date:  2010-09-19

2.  The art of fetoscopy: a step toward minimally invasive fetal therapy.

Authors:  Dipika Deka; Vatsla Dadhwal; S B Gajatheepan; Aprajita Singh; K Aparna Sharma; Neena Malhotra
Journal:  J Obstet Gynaecol India       Date:  2012-08-17

3.  Transabdominal embryofetoscopy for the detection of short rib-polydactyly syndrome, type II(Majewski), in the first trimester.

Authors:  Kook Lee; Jin Woo Lee; Doo Byung Chay; Sang Hee Lee; Si Hyun Cho; Bo Wook Kim; Ju Youn Hwang; Min Soo Park
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.